In Lewis lung carcinomas, the application of STING agonist could induce immune tolerogenic state by inhibitory signal indoleamine 2,3-dioxygenase (IDO), which protects cancer cell from immune attack and promotes tumor outgrowth [64, 65]. Here, STING1 is linked to neoplasm.